CARLY BOWLES: Open Payments
NPI 1710451521 · MATTHEWS, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,748 in 126 payments from 19 companies in 2025. Trend: 2023 $2,311 · 2024 $2,377 · 2025 $2,748
Food & beverage: $2,649Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $588 |
| Janssen Biotech, Inc. | 10 | $359 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 12 | $260 |
| Gilead Sciences, Inc. | 12 | $225 |
| PFIZER INC. | 10 | $201 |
| QOL Medical, LLC | 6 | $146 |
| Ardelyx, Inc. | 7 | $138 |
| Aimmune Therapeutics, Inc. | 5 | $136 |
| Lilly USA, LLC | 9 | $135 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $114 |
Products named: TREMFYA, RINVOQ, XIFAXAN, DUPIXENT, Sucraid, IBSRELA, ZENPEP, OMVOH.
Industry payments across NC — which companies pay providers there.
